| 000 | 01709 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515151547.0 | ||
| 264 | 0 | _c20090526 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1530-0285 | ||
| 024 | 7 |
_a10.1038/modpathol.2008.195 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChibon, Frédéric | |
| 245 | 0 | 0 |
_aPrediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations. _h[electronic resource] |
| 260 |
_bModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc _cMar 2009 |
||
| 300 |
_a403-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 17 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aGenes, erbB-2 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Hybridization |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xbiosynthesis |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _ade Mascarel, Isabelle | |
| 700 | 1 | _aSierankowski, Ghislaine | |
| 700 | 1 | _aBrouste, Véronique | |
| 700 | 1 | _aBonnefoi, Hervé | |
| 700 | 1 | _aDebled, Marc | |
| 700 | 1 | _aMauriac, Louis | |
| 700 | 1 | _aMacGrogan, Gaëtan | |
| 773 | 0 |
_tModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc _gvol. 22 _gno. 3 _gp. 403-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/modpathol.2008.195 _zAvailable from publisher's website |
| 999 |
_c18514839 _d18514839 |
||